When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

Revenues of €9.2 million for the full year of 2024Cash and cash equivalents at €96.6 million as of December 31, 2024 First tranche of up to €348 ...

It is nothing new that dogs have a much better nose than humans. A dog's nose has around 300 million olfactory cells, making it 40 times more powerful than that of a human. This is why their special ...

Preclinical studies have shown their potential to reduce inflammation and modulate immune responses in diseases like rheumatoid arthritis and lupus.

IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, today announced positive topline data from its Phase 1/2 clinical ...

Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, a ...